Every Cure
Legal name: Every Cure Inc
Nonprofit profile at a glance
- EIN
- 920240717
- IRS 990 coverage
- 2022–2025
- Official website data refreshed
- Sep 2026
- Forms available
- Form 990 2025
- Location
- Philadelphia, PA, USA
- Phone
- 4842856568
- Rating
- 67
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Medical Research N.E.C.
Reported finances
- Revenue
- $34,822,357
- Expenses
- $12,134,310
- Assets
- $74,089,051
- Liabilities
- $2,166,351
Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
17 people listed
Executive titles in this filing
- DAVID FAJGENBAUM (CO-FOUNDER & PRESIDENT)
- GRANT MITCHELL (FORMER CEO & TREASURER)
Highest reported compensation
- ALEXANDER PAMPALONE (CHIEF PHILANTHROPY OFFICER): $365,720 total reported compensation
- MARY ZUCCATO (CHIEF OPERATING OFFICER): $305,027 total reported compensation
- CHARLOTTE HEMPSTEAD (CHIEF PLATFORM OFFICER): $290,333 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Every Cure is on a mission to unlock hidden cures and ensure no patient suffers when an existing drug could help them.
What it reported doing in 2025
Education and awareness-raising on drug repurposing: every cure educates physicians, researchers, patients, policymakers, and the general public about the potential for drug repurposing to accelerate cures. Education and outreach are central to creating a shift in drug discovery and the practice of medicine, where existing therapies are fully leveraged for diseases beyond their original approvals. In 2025, we reached millions of people with our mission through social media and press coverage, including a ted talk by our founder, highlighting the story of drug repurposing and every cure's mission which increased visibility and engagement with our work. We have disseminated scientific findings through presentations at international scientific meetings, invited talks at research institutions, and publication of educational content in professional outlets to increase awareness among physicians and scientists. These educational activities increased awareness of drug repurposing among healthcare professionals, researchers, policymakers, patients, and the public, helping to foster collaboration and support the responsible advancement of drug repurposing across the healthcare ecosystem.
Operating model
- Revenue model
- Mixed. Its operating money came from several sources; no one source provided a clear majority.
- Distribution model
- Hybrid. The nonprofit split its reported program spending across 70% for direct work, and 30% for grants.
The verdict
SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and the filing reports few safeguards for money sent abroad.
Rating breakdown
- Financial Efficiency: 49
- Transparency & Controls: 70
- Accountability: 85
- Sustainability: 79
- Growth: 100
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 29%; rating input score 29
- Program expense ratio: 75.5%; rating input score 75
- Fundraising efficiency: $43.79 raised per $1 spent on fundraising; rating input score 72; 72nd percentile among comparable filings
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 64th percentile among comparable filings
- Pay-setting controls: 3 of 6 controls in place; rating input score 50
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Pass
- Written employment contract: Missing
- Compensation survey or study: Pass
- Board or committee approval: Pass
- Foreign activity oversight: Scored; rating input score 0
- Grant itemization coverage: 100%; rating input score 100; 76th percentile among comparable filings
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: 75%; rating input score 75; 12th percentile among comparable filings
- Governance controls: 9 of 9 controls in place; rating input score 100
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: Pass
- Other executive compensation review process: Pass
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: 65.2%; rating input score 95; 95th percentile among comparable filings
- Total-asset coverage ratio: 6.11; rating input score 81; 81st percentile among comparable filings
- Liabilities to assets ratio: 0.03; rating input score 83; 83rd percentile among comparable filings
- Officer compensation ratio: 20.2%; rating input score 6; 6th percentile among comparable filings
Growth
- Program expense growth: 84.1% per year; rating input score 100; 99th percentile among comparable filings
- Revenue growth: 67.6% per year; rating input score 100; 99th percentile among comparable filings
- Asset growth: 83.4% per year; rating input score 100; 99th percentile among comparable filings
Details
- What they do: 1 programs and campaigns described on the official site
- Where the money goes: 29% of revenue deployed · 75.5% of spending went to programs
- Governance: 6 of 8 board members independent · 9 of 9 filing controls reported
- Programs: 3 filed program accomplishments · $9.2M in reported program spending
- Leadership: top reported pay $366K · 17 people listed · 3 of 6 pay-setting controls reported
- Highest-paid contractors: 4 contractors listed · $617K reported
- Consistency: 34 of 34 current checks pass
- Schedules: 7 filed schedules · includes major donors, foreign activity, grants, and executive pay
- Filing history: 4 filing years from 2022 to 2025
- Contacts: How to reach this organization
- Money network: 16 filed money-flow records
- Related organizations: 5 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
- Staff and benefit plans: Retirement and health plans the organization files with the Department of Labor, and the people in them.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Financial Efficiency: Mission deployment rate scored 29/100.
- High — Transparency & Controls: Foreign activity oversight scored 0/100.
- High — Sustainability: Officer compensation ratio scored 6/100.